| Literature DB >> 32456252 |
Noelia Tena1, Julia Martín2, Agustín G Asuero1.
Abstract
The antioxidant activity of anthocyanins in food is well known. Numerous antioxidant assays have been proposed to measure the capacity of anthocyanins to prevent the oxidation process that naturally occurs. Different solvents, temperatures, and pH levels are applied in each assay, and these factors should be taken into account in order to obtain useful and reproducible results. The concentration and the structure of these compounds are directly related to their antioxidant capacity and their environment. However, the effectiveness of the anthocyanin ingestion against diseases is also influenced by its bioavailability. Novel methodologies that simulate the digestion process have been developed in order to facilitate the current knowledge of anthocyanins bioavailability. Studies highlight the potential synergy effect between parent compounds and their derivatives (metabolites, conjugated products, and microbe-generated metabolites). The aim of this review is to provide an overview of advantages and disadvantages of the most common methods to determine the antioxidant activity of anthocyanins, chemical structure, and concentration of these compounds in different edible fruits, vegetables, and plants; their bioavailability after intake; as well as the main therapeutic effect described in the scientific literature.Entities:
Keywords: anthocyanin content; anthocyanins; antioxidant activity; bioavailability; encapsulation; therapeutic effects
Year: 2020 PMID: 32456252 PMCID: PMC7278599 DOI: 10.3390/antiox9050451
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Commonly used methods for measurement in vitro of antioxidant activity
| Bioassay | Reagents Involved in the Reaction | Detection | Method |
|---|---|---|---|
| DPPH (Diphenyl-1-picrylhydrazyl) assay | Free radical (DPPH•+) | Decrease of Abs. at 515 nm | Spectrophotometric |
| ORAC Assay (Oxygen Radical Absorbance Capacity) | 2,2′-azobis(2-amidino-propane) dihydrochloride (AAPH) to produce free radical | Decrease of fluorescence | Fluorescence spectroscopy |
| TRAP assay (total peroxyl radical trapping antioxidant parameter) | 2,2′-azobis(2-amidopropane) hydrochloride (ABAP) to produce free radical | Decrease of luminescence | Chemiluminescence |
| FCT (ferric thiocyanate) assay | Ferrous chloride, formation of red ferric thiocyanate | Increase of Abs. at 500 nm | Spectrophotometric |
| FRAP (Ferric Reducing Antioxidant Power) assay | FeCl3·6H2O, formation of blue ferrous complexes | Increase of Abs. at 593 nm | Colorimetric |
| CUPRAC, Cupric Ion Reducing Antioxidant Capacity | Cupric neocuproine, formation of Cu(I)-neocuproine | Increase of Abs. at 550 nm | Spectrophotometric |
| ABTS [2,2′-azino-bis (3-ehtylbenzothiazoline-6-sulfonic acid) diamonium salt] assay | Free radical (ABTS•+) | Decrease of Abs. at 415 nm | Colorimetric |
| Methods of inhibited autoxidation | Lipid molecules, azoinitiator | O2 consumption/hydroperoxide formation | Oxygen electrode, pressure gauge, detection of conjugated dienes |
Note: Abs, absorbance.
Figure 1Structure of anthocyanins R3 = sugar, and anthocyanidins R3 = H.
Anthocyanins identified in different fruits, vegetables, and edible flowers and their codes.
| Code | Anthocyanin | Code | Anthocyanin |
|---|---|---|---|
| 1 | Delphinidin | 30 | Petunidin 3-arabinoside |
| 2 | Delphinidin 3-arabinoside | 31 | Petunidin 3-galactoside |
| 3 | Delphinidin 3-galactoside | 32 | Petunidin 3-glucoside |
| 4 | Delphinidin 3-glucoside | 33 | Petunidin 3-halactoside |
| 5 | Delphinidin 3,5-diglucoside | 34 | Petunidin 3-rutinoside |
| 6 | Delphinidin 3-rutinoside | 35 | Peonidin |
| 7 | Delphinidin 3- | 36 | Peonidin 3-galactoside |
| 8 | Cyanidin | 37 | Peonidin 3-glucoside |
| 9 | Cyanidin 3-arabidoside | 38 | Peonidin 3-rutinoside |
| 10 | Cyanidin 3-galactoside | 39 | Peonidin 3-(6′-malonylglucoside) |
| 11 | Cyanidin 3-glucoside | 40 | Peonidin 3-(3″,6″-dimalonylglucoside) |
| 12 | Cyanidin 3,5-diglucoside | 41 | Peonidin 3-glucoside/malvidin 3-galactoside |
| 13 | Cyanidin 3-rutinoside | 42 | Peonidin 3-arabinoside/malvidin 3-glucoside |
| 14 | Cyanidin 3-(6′-malonylglucoside) | 43 | Peonidin 3- |
| 15 | Cyanidin 3-(3″,6″-dimalonylglucoside) | 44 | Peonidin 3- |
| 16 | Cyanidin 3-xyloside | 45 | Peonidin 3-caffeoylsophoroside-5-glucoside |
| 17 | Cyanidin 3-xylosylrutinoside | 46 | Peonidin 3-dicaffeoylsophoroside-5-glucoside |
| 18 | Cyanidin 3-dioxaloylglucoside | 47 | Peonidin 3-caffeoyl- |
| 19 | Cyanidin 3-halavtoside | 48 | Peonidin 3-caffeoy-feruloylsophoroside-5-glucoside |
| 20 | Cyanidin 3- | 49 | Malvidin |
| 21 | Cyanidin 3-sophoroside-5-rhamnoside | 50 | Malvidin 3-arabinoside |
| 22 | Cyanidin 3-sambubioside | 51 | Malvidin 3-galactoside |
| 23 | Cyanidin 3-sambubioside-5-rhamnoside | 52 | Malvidin 3-glucoside |
| 24 | Cyanidin-3- | 53 | Malvidin 3,5-diglucoside |
| 25 | Cyanidin-3-caffeoylsophoroside-5-glucoside | 54 | Pelargonidin |
| 26 | Cyanidin-3-caffeoyl- | 55 | Pelargonidin 3-glucoside |
| 27 | Cyanidin 3-( | 56 | Pelargonidin 3-rutinoside |
| 28 | Cyanidin 3-( | 57 | Pelargonidin 3,5-diglucoside |
| 29 | Petunidin |
Figure 2Effect of pH on the structure and color of anthocyanins.
Figure 3Schematic representation of the anthocyanins chemical structures influenced by the digestion process steps (R2 and R3 = H or Methyl) (taken from Braga et al. [14], with permission of Elsevier).
Figure 4Scheme of anthocyanins metabolites from colonic metabolism and colon microbiota alteration.
Health benefits of anthocyanins.
| Eye Health | Administration | References |
|---|---|---|
| Improvement of vision in patients with open-angle glaucoma | Oral capsule | [ |
| Protective effect during retinal inflammation | IV in rats | [ |
| Regeneration of rhodopsin and smooth muscle relaxation | IV in mouse model | [ |
| Improvement of dark adaptation | Oral capsule | [ |
| Prevention of cataractogenesis of diabetic cataract | Incubation of Enucleated rat lenses | [ |
| Antiapoptotic effects against oxidative damage of lens epithelial cell | Cell studies | [ |
| Prevention of retinal degeneration induced by N-methyl-N-nitrosourea | Oral solution | [ |
| Increase of ocular blood flows | Oral capsule | [ |
|
| ||
| Inhibition of platelet aggregation (in vitro antithrombotic properties) | Cell studies | [ |
| Increase of high-density lipoprotein cholesterol levels and decrease of low-density lipoprotein cholesterol levels | Oral capsule | [ |
| Lower risk of non-fatal myocardial infarction | Oral intake | [ |
| Vasorelaxation properties in isolated coronary artery rings in pigs | Cell studies | [ |
| Decrease of susceptibility to ischemia-reperfusion injury and infarct size | Rodent food | [ |
| Improvement of lipid profile and platelet function | Oral capsule | [ |
|
| ||
| Improvement of weight gain and lipid profile on obese rats | Fat diet-induced mouse model | [ |
| Suppression of body weight gain and improve blood lipid profile in rats | Fat diet-induced mouse model | [ |
| Reduction of sugar concentration in urine and plasma in rats | Intraperitoneal and intragastric administration | [ |
| Ameliorated obesity in high-fat-fed mice | Cell studies | [ |
| Upregulation of adipocytokine secretion and gene expression in rat adipocytes | Cell studies | [ |
| Suppression of fat tissue gain, weight gain and other metabolic disorders | Fat diet-induced mouse model | [ |
|
| ||
| Amelioration of hyperglycemia and insulin sensitivity in diabetic mice | Fat diet-induced mouse model | [ |
| Improvement of dyslipidemia, enhancement of antioxidant capacity, and prevention of insulin resistance in human with type 2 diabetes | Oral capsule | [ |
| Alleviation of glomerular angiogenesis of diabetic kidneys in mice | Cell studies | [ |
| Inhibition of DPP IV activity (a protease that regulates blood glucose levels via degradation of incretins) | Computational studies | [ |
| Amelioration of renal apoptosis in diabetic nephropathy mice | Oral solution | [ |
| Activation of adipose tissue-derived adiponectin to defend against diabetes-related endothelial dysfunction in mice | Diet-induced mouse model | [ |
|
| ||
| Induction of cell damage by destroying the cell wall, membrane, and intercellular matrix | Cell studies | [ |
| Highest sensitivity to | Microbial strains | [ |
| Antibacterial effects towards | Microbial strains | [ |
| Inhibition of Gram-negative bacteria | Microbial strains | [ |
|
| ||
| Suppression of cell proliferation, inflammation, and angiogenesis and induction of apoptosis in esophageal tissue of rats | Diet-induced rat model | [ |
| Anti-invasive potential in breast cancer cell lines | Cell studies | [ |
| Anticancer effect on BALB/c nude mice bearing MDA-MB-453 cell xenografts and breast cancer cell lines | Cell studies | [ |
| Inhibition of cell migration and invasion, suppression of activation of rapidly accelerated fibrosarcoma, mitogen-activated protein kinase and c-Jun N-terminal kinase, and downregulation of secretion of matrix metalloproteinase 2 | Cell studies | [ |
| Inhibition of growth of human HT-29 colon cancer cells, increase of expression of tumor suppression genes and decrease of cyclooxygenase-2 gene expression | Cell studies | [ |
| Reduction of colonic aberrant crypt foci, colonic cellular proliferation and COX-2 mRNA expression in rats | Diet-induced rat model | [ |
| Suppression of formation of aberrant crypt foci in colons of CF-1 mice | Cell studies and diet-induced rat model | [ |
| Promotion of apoptosis in benign prostatic hyperplasia rats | Oral doses in rat model | [ |
| Anti-invasive effect on human hepatoma Hep3B cells and inhibition of matrix metalloproteinase MMP-2 and MMP-9 gene expression | Cell studies | [ |
| Inhibition of Akt-mTOR signaling thereby inducing maturation of acute myeloid leukemia cells, besides inducing apoptotic players such as TRAIL in cancer systems | Cell studies | [ |
|
| ||
| Neuroprotective activity by suppression of dopaminergic cell death in Parkinson’s disease | Cell studies | [ |
| Improvement of learning and memory ability in mice. Higher antioxidant enzyme activity and less lipid oxidation in both brain and liver | Diet-induced mouse model | [ |
| Regulation of cholinergic neurotransmission to restore Na+, K+-ATPase and Ca2+-ATPase activities and to prevent memory deficits in rats | Oral and injected rat models | [ |
| Neuroprotective effect: Memory and synaptic dysfunction | Oral rat models | [ |
| Improvement of its free radical scavenging capabilities via p38/JNK pathway against Abeta1-42-induced oxidative stress | Cell studies | [ |
| Enhancement of neuroprotection against Abeta1-42-induced neuroinflammation and neurodegeneration | Oral mouse model and cell studies | [ |
| Enhancement of the neuroprotection in an Abeta1-42 mouse model of Alzheimer’s disease | Oral mouse model and cell studies | [ |